Aster Biofabrication

Teams working on human tissue models face a gap between research demonstrations and manufacturable products. The page states that tissue models can only replace animal models if they are treated as products rather than one-off demonstrations, which implies that without structured, consistent data behind each run, quality and reproducibility break down from batch to batch. This suggests biofabrication groups currently lack a unified system to coordinate the fabrication, recording, analysis and prediction steps of tissue production, leaving results difficult to trust or scale.

Aster's product, Capitula, is a data platform built around five coordinated modules that cover the full tissue manufacturing workflow: BioSlicer handles fabrication, Calendula records data, Helianthus analyzes it, Solidago predicts outcomes, and Cosmos coordinates the modules together. The design intent is that each module's output feeds into the next, structuring the data behind every run so that quality holds consistent across batches. The company frames this as infrastructure for turning tissue manufacturing into a repeatable, product-grade process rather than isolated experiments.